Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Saved in:
| Title: | Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study. |
|---|---|
| Authors: | Dove LS; Furiex Pharmaceuticals, Morrisville, North Carolina 27560, USA. scott.dove@furiex.com, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS |
| Source: | Gastroenterology [Gastroenterology] 2013 Aug; Vol. 145 (2), pp. 329-38.e1. Date of Electronic Publication: 2013 Apr 09. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
